Centiva Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Centiva Capital’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,144	Closed	-$850K	–	1970
2021 Q4	$850K	Buy	+9,144	New	+$602K	0.02%	672

Centiva Capital's ARNA Position: Q1 2022 in Review

Centiva Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 9,144 shares — an estimated $850K sold.

Centiva Capital first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $850K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Centiva Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Centiva Capital sold 9,144 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $850K.
Centiva Capital first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Centiva Capital's Arena Pharmaceuticals Inc position peaked at $850K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Centiva Capital's 13F filing for Q1 2022, filed 16 May 2022.